Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions.
- 2025-03-21
- Applied microbiology and biotechnology 109(1)
- Yi-Lin Chan
- Jun-Cheng Liao
- Tsung-Lin Li
- Chang-Jer Wu
- Yi-Han Chiu
- PubMed: 40116950
- DOI: 10.1007/s00253-025-13445-x
- Low evidence
- Animal Study
Further analysis using 16S rDNA sequencing suggested that both B. lactis P and B. lactis S optimize gut microbiota
- Effect
- Beneficial
- Effect size
- Moderate